METSERA, INC.
MTSRLoading price...
Overview
Previous Close60.73
Open68.90
Ask84.35
Bid72.10
Day's Range68.00 - 74.24
52 Week Range12.30 - 74.24
PE Ratio(TTM)--
Market Cap7.7B
Volume9.73M
Avg. Volume2.27M
Profit/Loss
| PARTICULARS | ||||||
|---|---|---|---|---|---|---|
| No results to display | ||||||
Company Profile
Sector: Healthcare
Industry: Biotechnology
HQ Location: New York, United States
Website: https://metsera.com
Co-Founder & Executive Chairman: Dr. Clive A. Meanwell M.D., Ph.D.
Employees: 104
About Company:
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.